FDA approves a new treatment for KRAS G12C-mutated metastatic colorectal cancer, showing significant progression-free ...
The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...
Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...
THOUSAND OAKS, Calif. - Amgen (NASDAQ:AMGN), a prominent biotechnology company with a market capitalization of $144.8 billion, has received FDA approval for LUMAKRAS® (sotorasib) in combination with ...
The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free ...
In nearly seven years as Quebec City's only patient navigator for Anglophones, he's met over 500 patients just like her. "It's a godsend that Steve and the services are here to help us," said ...
with four points and two clean sheets to show for it. The first half saw Burnley clock up 70 per cent of possession but Stoke limited how much they could get into the area and were content to ...
Copyright 2025 The Associated Press. All Rights Reserved. Patients left the European Hospital in the southern city of Khan Younis early Tuesday, accompanied by more ...
Nurses at Saint Vincent Hospital in Worcester allege that cost-saving measures are causing pervasive lapses in care, including two patients dying after failing to receive potentially life-saving ...
Israeli forces raided a hospital in northern Gaza, ordering dozens of patients and hundreds of other people to evacuate, according to the Hamas-run Palestinian health ministry. On Friday ...
The FDA's conditional approval for Lumakras (sotorasib; formerly AMG-510 ... diagnostics from Guardant Health and Qiagen to identify patients eligible for treatment with the new drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback